Millennium Management LLC and Affiliates File Schedule 13G for ALX Oncology Holdings Inc.

Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have filed a Schedule 13G with the SEC, disclosing their beneficial ownership of 5.1% of the common stock of ALX Oncology Holdings Inc. The filing, dated October 7, 2025, indicates that the shares are held by entities subject to voting control and investment discretion by Millennium Management LLC and/or other investment managers controlled by Millennium Group Management LLC and Israel A. Englander. The filing includes a Joint Filing Agreement confirming that the Schedule 13G is filed on behalf of each of the entities and individuals named. The filing is made pursuant to Rule 13d-1(c) under the Securities Exchange Act of 1934.